US Capitol Capsule: Flu vax up, but CDC hopes new options boost rates
This article was originally published in Scrip
While US immunization rates against influenza during the 2012-13 season were better than they had ever been before, health officials are hoping the ample supplies and newer options of vaccine for the upcoming season will boost the number of Americans getting vaccinated.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.